Nonalcoholic fatty liver disease in adults: current concepts in etiology, outcomes, and management
T Marjot, A Moolla, JF Cobbold, L Hodson… - Endocrine …, 2020 - academic.oup.com
Nonalcoholic fatty liver disease (NAFLD) is a spectrum of disease, extending from simple
steatosis to inflammation and fibrosis with a significant risk for the development of cirrhosis. It …
steatosis to inflammation and fibrosis with a significant risk for the development of cirrhosis. It …
Pathophysiology of sleep apnea
JA Dempsey, SC Veasey, BJ Morgan… - Physiological …, 2010 - journals.physiology.org
Sleep-induced apnea and disordered breathing refers to intermittent, cyclical cessations or
reductions of airflow, with or without obstructions of the upper airway (OSA). In the presence …
reductions of airflow, with or without obstructions of the upper airway (OSA). In the presence …
Obstructive sleep apnea, hypoxia, and nonalcoholic fatty liver disease
Recent studies have demonstrated that obstructive sleep apnea (OSA) is associated with the
development and evolution of nonalcoholic fatty liver disease (NAFLD), independent of …
development and evolution of nonalcoholic fatty liver disease (NAFLD), independent of …
The impact of sleep disorders on glucose metabolism: endocrine and molecular mechanisms
A Briançon-Marjollet, M Weiszenstein, M Henri… - Diabetology & metabolic …, 2015 - Springer
Modern lifestyle has profoundly modified human sleep habits. Sleep duration has shortened
over recent decades from 8 to 6.5 hours resulting in chronic sleep deprivation. Additionally …
over recent decades from 8 to 6.5 hours resulting in chronic sleep deprivation. Additionally …
The epidemiology of nonalcoholic fatty liver disease: a global perspective
Nonalcoholic fatty liver disease (NAFLD) is an increasingly recognized cause of liver
disease in the United States and worldwide. With obesity being an important risk factor …
disease in the United States and worldwide. With obesity being an important risk factor …
Hepatocyte TLR4 triggers inter-hepatocyte Jagged1/Notch signaling to determine NASH-induced fibrosis
Aberrant hepatocyte Notch activity is critical to the development of nonalcoholic
steatohepatitis (NASH)–induced liver fibrosis, but mechanisms underlying Notch reactivation …
steatohepatitis (NASH)–induced liver fibrosis, but mechanisms underlying Notch reactivation …
NAFLD and extra-hepatic comorbidities: current evidence on a multi-organ metabolic syndrome
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
worldwide and its incidence is definitely increasing. NAFLD is a metabolic disease with …
worldwide and its incidence is definitely increasing. NAFLD is a metabolic disease with …
[PDF][PDF] Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression
O Cheung, P Puri, C Eicken, MJ Contos… - …, 2008 - Wiley Online Library
The expression of microRNA in nonalcoholic steatohepatitis (NASH) and their role in the
genesis of NASH are not known. The aims of this study were to:(1) identify differentially …
genesis of NASH are not known. The aims of this study were to:(1) identify differentially …
[HTML][HTML] Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions
Non-alcoholic fatty liver disease (NAFLD) in children is becoming a major health concern. A
“multiple-hit” pathogenetic model has been suggested to explain the progressive liver …
“multiple-hit” pathogenetic model has been suggested to explain the progressive liver …
[HTML][HTML] Risk factors in nonalcoholic fatty liver disease
E Ko, EL Yoon, DW Jun - Clinical and molecular hepatology, 2023 - ncbi.nlm.nih.gov
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease, with a global
prevalence estimated at approximately 25%. NAFLD is also the leading cause of liver …
prevalence estimated at approximately 25%. NAFLD is also the leading cause of liver …